NL7204029A - - Google Patents

Info

Publication number
NL7204029A
NL7204029A NL7204029A NL7204029A NL7204029A NL 7204029 A NL7204029 A NL 7204029A NL 7204029 A NL7204029 A NL 7204029A NL 7204029 A NL7204029 A NL 7204029A NL 7204029 A NL7204029 A NL 7204029A
Authority
NL
Netherlands
Application number
NL7204029A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7204029A publication Critical patent/NL7204029A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NL7204029A 1971-03-27 1972-03-24 NL7204029A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712114884 DE2114884A1 (de) 1971-03-27 1971-03-27 Basisch substituierte Derivate des 1(2H)-Phthalazinons

Publications (1)

Publication Number Publication Date
NL7204029A true NL7204029A (en:Method) 1972-09-29

Family

ID=5802944

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7204029A NL7204029A (en:Method) 1971-03-27 1972-03-24

Country Status (12)

Country Link
US (1) US3845052A (en:Method)
AT (1) AT313290B (en:Method)
BE (1) BE781299A (en:Method)
CH (1) CH574938A5 (en:Method)
DD (1) DD98676A5 (en:Method)
DE (1) DE2114884A1 (en:Method)
FR (1) FR2132079B1 (en:Method)
GB (1) GB1365770A (en:Method)
HU (2) HU164874B (en:Method)
NL (1) NL7204029A (en:Method)
PL (1) PL88953B1 (en:Method)
SU (1) SU428602A3 (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665181A (en) * 1984-05-17 1987-05-12 Pennwalt Corporation Anti-inflammatory phthalazinones
EP0174464B1 (de) * 1984-09-14 1990-01-03 ASTA Pharma AG Substituierte Benzylphthalazinon-Derivate
DE3677322D1 (de) * 1985-11-11 1991-03-07 Asta Pharma Ag 4-benzyl-1-(2h)-phthalazinon-derivate.
US4868301A (en) * 1987-06-09 1989-09-19 Pfizer Inc. Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
LT2377557T (lt) 2004-11-24 2017-02-10 Meda Pharmaceuticals Inc. Kompozicijos, apimančios azelastiną, ir jų panaudojimo būdai
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof

Also Published As

Publication number Publication date
DE2114884A1 (de) 1972-10-12
DD98676A5 (en:Method) 1973-07-05
FR2132079B1 (en:Method) 1975-04-25
SU428602A3 (ru) 1974-05-15
AT313290B (de) 1974-02-11
FR2132079A1 (en:Method) 1972-11-17
HU164008B (en:Method) 1973-12-28
PL88953B1 (en:Method) 1976-10-30
HU164874B (en:Method) 1974-05-28
BE781299A (fr) 1972-09-27
US3845052A (en) 1974-10-29
GB1365770A (en) 1974-09-04
CH574938A5 (en:Method) 1976-04-30

Similar Documents

Publication Publication Date Title
FR2158546B1 (en:Method)
FR2132079B1 (en:Method)
CS168587B2 (en:Method)
CS173710B1 (en:Method)
CS173502B1 (en:Method)
AU4958672A (en:Method)
BE789167R (en:Method)
CH550886A (en:Method)
CH562315A5 (en:Method)
CH560677A5 (en:Method)
CH560109A5 (en:Method)
BG18000A1 (en:Method)
CH559707A5 (en:Method)
CH545840A (en:Method)
BG17237A1 (en:Method)
BG21382A3 (en:Method)
BG16948A1 (en:Method)
BG18710A1 (en:Method)
BG16806A1 (en:Method)
BG18039A1 (en:Method)
CH564573A5 (en:Method)
BE777547A (en:Method)
BE774406A (en:Method)
BG19679A1 (en:Method)
CH1415672A4 (en:Method)